Sitagliptin-placebo

DRUG2 trials

Sponsors

Amsterdam UMC, location VUmc, GWT-TUD GmbH

Conditions

Beta-cell FunctionDiabetes MellitusDiabetes Mellitus Type 2Glucocorticoid-induced DiabetesSteroid Diabetes

Phase 4

Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

TerminatedNCT02373865

GWT-TUD GmbHDiabetes Mellitus Type 2

Start: 2015-09-30End: 2017-01-31Updated: 2019-02-27

Unknown Phase

Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome

CompletedNCT00721552

Amsterdam UMC, location VUmcBeta-cell Function, Diabetes Mellitus, Glucocorticoid-induced Diabetes +1

Start: 2008-10-31End: 2012-06-30Updated: 2012-07-02

Related Papers

Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetes.

2012-11-2410 citations